General Resources on COVID-19
FDA Daily Roundup – Updates, announcements, and guidance from the U.S. Food and Drug Administration (FDA)
FDA FAQs – FDA answers frequently asked questions about food, medical treatment, devices, and veterinary products amid the COVID-19 pandemic
NIH Updates – News and resources from the National Institutes of Health
CDC Updates – News and weekly surveillance report from the Centers for Disease Control and Prevention (CDC)
HHS Updates – COVID-19 information from the U.S. Department of Health and Human Services
COVID-19 Pandemic Resources – Public and technical updates, including travel advice, from the World Health Organization (WHO)
Global Research on COVID-19 – Links to clinical trials around the world
Diagnostic Tests for COVID-19 – Information on tests available for detecting SARS-CoV-2 and a list of organizations offering testing and/or test kits
Glossary of Terms – A list of common terms and definitions related to drug development and expanded access
FDA Resources for Patients – Resources to help patients and caregivers cope with the COVID-19 pandemic
Hand Sanitizers and COVID-19 – Answers from FDA on common questions about hand sanitizer and antibacterial soap
Hand Sanitizer and Safety – FDA information regarding use of hand sanitizer and hygiene for consumers
Cloth Face Masks – CDC information regarding use of clothe face masks to slow the spread of COVID-19
How to Protect Yourself – Tips on how to protect yourself and what to do if you're sick
Know the Symptoms – List of symptoms and a self-checker
Patients & Caregivers Guide to Expanded Access – Detailed guide to help patients and caregivers understand the process of accessing investigational drugs when a clinical trial is not an option
Blood Purification Device Authorized – FDA authorizes blood purification system to treat patients 18 and older with COVID-19
Chloroquine and Hydroxychloroquine – FDA revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine
Coronavirus Treatment Acceleration Program (CTAP) – Special emergency program created by FDA to expedite the availability of potentially safe and effective life-saving treatments
Emergency Use Authorizations – Lists current and terminated EUAs that make available diagnostic and therapeutic medical devices to diagnose and respond to public health emergencies
Expanded Access Navigator Guide for Healthcare Providers – Detailed guide to help physicians and healthcare providers request and manage access to investigational treatments outside of a clinical trial
Guidance for IRBs and Clinical Investigators – Institutional Review Board (IRB) Review of individual patient expanded access requests for investigational drugs and biological products during the COVID-19 public health emergency
Guidance for Industry, Investigators, and Institutional Review Boards – FDA guidance on conduct of clinical trials of medical products during COVID-19 public health emergency
Hospital Beds, Stretchers, and Mattresses – FDA FAQs to address questions related to design, evaluation, labeling, and marketing
Laboratory Safety – Guidance on workflow safety concerns of laboratory personnel during the COVID-19 pandemic
Medical Devices and the COVID-19 Pandemic –Information from FDA on diagnostic tests, ventilators, and personal protective equipment (PPE), including masks, face shields, respirators, gowns, and gloves
Medical Gloves for COVID-19 – Information from FDA on manufacturing, purchasing, importing, and donating gloves during the public health emergency
Remdesivir and chloroquine phosphate or hydroxychloroquine – Press release from FDA issuing warning of newly discovered potential drug interaction that may reduce effectiveness of a COVID-19 treatment authorized for Emergency Use
Testing Healthcare Personnel for SARS-CoV-2 – CDC summary of considerations and recommendations regarding testing healthcare personnel (HCP) for SARS-CoV-2.
Therapuetic Emergency Use Authorization – Details the FDA-issued EUA allowing distribution of hydroxychloroquine sulfate and chloroquine phosphate from the Strategic National Stockpile for certain hospitalized patients with COVID-19
Treatment Guidelines – NIH key updates to COVID-19 treatment guidelines
Treatment Summary Recommendations – NIH recommendations for care of critically ill patients with COVID-19
Personal Protective Equipment:
Revised EUA for Respirators – FDA reissues Emergency Use Authorizations revising which types of respirators can be decontaminated for reuse
EUA to Detcontaminate Respirators – FDA's Emergency Use Authorization to decontaminate millions of n95 respirators
Mask and Gown Shortage FAQs – Answers to frequently asked questions on shortages of surgical masks and gowns
Masks and N95 Respirators – Information about the use of N95 vs surgical or face masks
Medical Devices and the COVID-19 (Coronavirus) Pandemic – Information from FDA on diagnostic tests, ventilators, and personal protective equipment (PPE)—including masks, face shields, respirators, gowns, and gloves
Medical Glove Conservation Strategies – Letter from FDA to healthcare providers on potential shortages of surgeons' gloves and patient examination gloves
PPE Conservation – Strategies to conserve PPE and other resources
Surgical Mask and Gown Conservation Strategies – Letter from FDA to healthcare providers recommending conservation strategies for a range of need and supply levels
Facepiece respirators – Letter from FDA to healthcare providers advising that certain filtering facepiece respirators from China may not provide consistent and adequate respiratory protection to health care personnel exposed to COVID-19